Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial.

Background: The effects of different hypolipidemic treatment strategies on emerging atherosclerosis risk factors remain unknown.

Materials And Methods: This is a prespecified analysis of a prospective, randomized, open-label, blinded end point (PROBE) study (ClinicalTrials.gov identifier: NCT01010516).